Mayne Pharma Inc is recalling 1,440 cartons of Clonidine Transdermal System (clonidine), USP 0.3 mg/day. The recall was initiated because the delivery system is defective; specifically, the force required to remove the release liner from the patch was found to be out of specification during stability testing. No incidents or injuries have been reported to date. This prescription medication was distributed to pharmacies nationwide across the United States.
A defective release liner may make it difficult to properly apply the patch or could damage the medication-delivery layer, potentially resulting in the patient receiving an incorrect dose of the blood pressure medication.
You have 2 options:
Quantity: 1440 cartons
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.